WHO: Co-infection of Tuberculosis and HIV in Europe Increases
Copenhagen, March 21 (Prensa Latina) A report by the World Health Organization (WHO) regional office released today indicates that tuberculosis co-infection and the Human Immunodeficiency Virus (HIV) increased in Europe by 40 percent.
According to the document, developed jointly by the European Center for Disease Prevention and Control (ECDC) and the WHO, between 2011 and 2015 the deadly combination of both diseases went from 5.5 to 9 percent.
Of the 27,000 new estimated cases of co-infection in 2015, only about two-thirds were diagnosed and about five thousand 800 started antiretroviral treatment, with a success rate of 40 percent, according to the report.
The study highlights that for those infected with these diseases it is seven times more likely for the treatment to be ineffective and they are three times more likely to die than those infected with only tuberculosis.
Also, it added, multidrug-resistant tuberculosis (MDR-TB) cases in the region are increasing, which represented 20 percent worldwide in 2015.
The outbreak of co-infections and high rates of multidrug-resistant tuberculosis (MDR-TB) seriously threaten progress in ending that infection, a goal that European and global leaders have committed to achieve by 2030, said WHO Regional Director for Europe Zsuzsanna Jakab.
|By the minute||Most read|